SK281577B6 - Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze - Google Patents
Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze Download PDFInfo
- Publication number
- SK281577B6 SK281577B6 SK1287-95A SK128795A SK281577B6 SK 281577 B6 SK281577 B6 SK 281577B6 SK 128795 A SK128795 A SK 128795A SK 281577 B6 SK281577 B6 SK 281577B6
- Authority
- SK
- Slovakia
- Prior art keywords
- alkyl
- pyran
- tetrahydro
- phenyl
- mmol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9401747 | 1994-10-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK128795A3 SK128795A3 (en) | 1996-07-03 |
| SK281577B6 true SK281577B6 (sk) | 2001-05-10 |
Family
ID=14098722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1287-95A SK281577B6 (sk) | 1994-10-18 | 1994-10-18 | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP0787127B1 (cs) |
| JP (1) | JP3032579B2 (cs) |
| CN (1) | CN1093536C (cs) |
| AT (1) | ATE198474T1 (cs) |
| AU (1) | AU681520B2 (cs) |
| BG (1) | BG61768B1 (cs) |
| CA (1) | CA2202057C (cs) |
| CO (1) | CO4480026A1 (cs) |
| CZ (1) | CZ287350B6 (cs) |
| DE (1) | DE69519804T2 (cs) |
| DK (1) | DK0787127T3 (cs) |
| ES (1) | ES2153033T3 (cs) |
| FI (1) | FI971632A0 (cs) |
| GR (1) | GR3035471T3 (cs) |
| HU (1) | HU221543B (cs) |
| IL (1) | IL115581A (cs) |
| LV (1) | LV11468B (cs) |
| MY (1) | MY114680A (cs) |
| NO (1) | NO314629B1 (cs) |
| NZ (1) | NZ285163A (cs) |
| PE (1) | PE49196A1 (cs) |
| PL (1) | PL180104B1 (cs) |
| RU (1) | RU2136666C1 (cs) |
| SI (1) | SI9500392A (cs) |
| SK (1) | SK281577B6 (cs) |
| TR (1) | TR199501274A2 (cs) |
| TW (1) | TW411339B (cs) |
| UA (1) | UA45312C2 (cs) |
| WO (1) | WO1996011911A1 (cs) |
| YU (1) | YU65995A (cs) |
| ZA (1) | ZA958748B (cs) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6239285B1 (en) | 1998-02-06 | 2001-05-29 | Pfizer Inc | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| US6194585B1 (en) * | 1998-12-22 | 2001-02-27 | Pfizer Inc. | Process for preparing 5-lipoxygenase inhibitors |
| US6346624B1 (en) * | 1999-08-31 | 2002-02-12 | Pfizer Inc | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| US6344563B1 (en) * | 1999-08-31 | 2002-02-05 | Timothy Norris | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| SG87145A1 (en) * | 1999-08-31 | 2002-03-19 | Pfizer Prod Inc | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| CN1321112C (zh) | 2000-03-24 | 2007-06-13 | 欧洲凯尔特股份有限公司 | 作为钠通道阻滞剂的芳基取代的吡唑、三唑和四唑化合物 |
| DE60234822D1 (de) * | 2001-04-20 | 2010-02-04 | Novozymes As | Lipoxygenase-varianten und ihre verwendung |
| GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| CA2667566C (en) * | 2006-11-27 | 2012-01-03 | Pfizer Products Inc. | Pyrazole analogs |
| AU2008331199A1 (en) * | 2007-11-26 | 2009-06-04 | Pfizer Inc. | Pyrazole derivatives as 5-LO inhibitors |
| IN2014MN01839A (cs) * | 2012-02-28 | 2015-07-03 | Piramal Entpr Ltd | |
| PT3762368T (pt) | 2018-03-08 | 2022-05-06 | Incyte Corp | Compostos de aminopirazina diol como inibidores de pi3k-y |
| WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0462830B1 (en) * | 1990-06-21 | 1995-10-18 | Zeneca Limited | Cyclic ether derivatives |
| IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
| EP0505122A1 (en) * | 1991-03-21 | 1992-09-23 | Zeneca Limited | Alpha, alpha-dialkylbenzyl derivatives |
| EP0540165A1 (en) * | 1991-10-03 | 1993-05-05 | Zeneca Limited | Alkanoic acid derivatives |
| CN1050840C (zh) * | 1993-06-14 | 2000-03-29 | 美国辉瑞有限公司 | 咪唑脂氧合酶抑制剂 |
-
1994
- 1994-10-18 SK SK1287-95A patent/SK281577B6/sk unknown
-
1995
- 1995-05-29 JP JP8513058A patent/JP3032579B2/ja not_active Expired - Fee Related
- 1995-05-29 CN CN95195926A patent/CN1093536C/zh not_active Expired - Fee Related
- 1995-05-29 WO PCT/IB1995/000408 patent/WO1996011911A1/en active IP Right Grant
- 1995-05-29 AT AT95918121T patent/ATE198474T1/de not_active IP Right Cessation
- 1995-05-29 NZ NZ285163A patent/NZ285163A/en unknown
- 1995-05-29 CZ CZ19971177A patent/CZ287350B6/cs not_active IP Right Cessation
- 1995-05-29 PL PL95319727A patent/PL180104B1/pl not_active IP Right Cessation
- 1995-05-29 ES ES95918121T patent/ES2153033T3/es not_active Expired - Lifetime
- 1995-05-29 RU RU97106099/04A patent/RU2136666C1/ru not_active IP Right Cessation
- 1995-05-29 HU HU9701853A patent/HU221543B/hu not_active IP Right Cessation
- 1995-05-29 EP EP95918121A patent/EP0787127B1/en not_active Expired - Lifetime
- 1995-05-29 DE DE69519804T patent/DE69519804T2/de not_active Expired - Fee Related
- 1995-05-29 CA CA002202057A patent/CA2202057C/en not_active Expired - Fee Related
- 1995-05-29 AU AU24174/95A patent/AU681520B2/en not_active Ceased
- 1995-05-29 DK DK95918121T patent/DK0787127T3/da active
- 1995-09-12 TW TW084109522A patent/TW411339B/zh not_active IP Right Cessation
- 1995-10-02 CO CO95045652A patent/CO4480026A1/es unknown
- 1995-10-12 IL IL11558195A patent/IL115581A/xx not_active IP Right Cessation
- 1995-10-13 UA UA95104510A patent/UA45312C2/uk unknown
- 1995-10-16 MY MYPI95003103A patent/MY114680A/en unknown
- 1995-10-17 LV LVP-95-313A patent/LV11468B/en unknown
- 1995-10-17 ZA ZA958748A patent/ZA958748B/xx unknown
- 1995-10-17 PE PE1995282113A patent/PE49196A1/es not_active Application Discontinuation
- 1995-10-17 SI SI9500392A patent/SI9500392A/sl unknown
- 1995-10-17 YU YU65995A patent/YU65995A/sh unknown
- 1995-10-18 TR TR95/01274A patent/TR199501274A2/xx unknown
- 1995-10-18 BG BG100070A patent/BG61768B1/bg unknown
-
1997
- 1997-04-17 FI FI971632A patent/FI971632A0/fi not_active IP Right Cessation
- 1997-04-17 NO NO19971773A patent/NO314629B1/no unknown
-
2001
- 2001-02-23 GR GR20010400310T patent/GR3035471T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5883106A (en) | 5-lipoxygenase inhibitors | |
| SK281577B6 (sk) | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze | |
| US6063928A (en) | 5-lipoxygenase inhibitors | |
| US5753682A (en) | Imidazole lipoxygenase inhibitors | |
| US4560696A (en) | Analgesic, antipyretic or anti-inflammatory imidazole compounds | |
| JP3400392B2 (ja) | ５−リポキシゲナーゼ阻害剤及び新規医薬組成物 | |
| US4277486A (en) | 1-[(Substituted-naphthyl)ethyl]-imidazole derivatives | |
| FI101300B (fi) | Menetelmä farmakologisesti aktiivisten 1,2,3,4-tetrahydrokinoliini-6-e tikkahappojohdannaisten valmistamiseksi ja välituotteena käytettävät k inoliinijohdannaiset | |
| JP2843920B2 (ja) | イミダゾールリポキシゲナーゼ阻害剤 | |
| US4423057A (en) | Methods of use of 1-[(substituted-naphthyl)ethyl]-imidazole derivatives | |
| US4957931A (en) | Certain 1,2-benzisoxazole and 1,2-benzisothiazole derivatives | |
| KR100239930B1 (ko) | 5-리폭시게나제 저해제 | |
| PT787127E (pt) | Inibidores de 5-lipoxigenase | |
| JPS622586B2 (cs) | ||
| US20080262026A1 (en) | Therapeutic Agents 684 | |
| WO2008120000A1 (en) | Therapeutic agents |